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Abstract 
 
 
 The eIF3 is in yeast S. cerevisiae composed of five core essential subunits 
(TIF32, NIP1, PRT1, TIF34 and TIF35) and one nonessential substoichiometric 
subunit (HCR1), and as such represents the most complex initiation factor among all. 
Perhaps owing to that, it was shown to stimulate nearly all steps of the initiation 
pathway culminating in the formation of the 80S initiation complex at the AUG start 
codon on mRNA. Yeast eIF3 was also demonstrated to assemble together with the 
ternary complex, eIF1 and eIF5 into so called Multifactor complex that can exist free 
of ribosomes and whose formation greatly stimulates initiation efficiency. TIF32, the 
largest eIF3 subunit, was shown to make at least two critical contacts with the 40S 
ribosomal subunit and its middle domain, designated as the HLD, to share a 
significant sequence similarity with the HCR1 subunit. Experiments conducted here 
indicate that the TIF32-HLD and HCR1 share also some functional similarity as the 
recombinant HLD expressed under control of the HCR1 promoter in a domain-
swapping experiment partially suppressed the slow growth phenotype of cells deleted 
for HCR1. In addition to the HLD, HCR1 also simultaneously interacts with the 
RRM domain of PRT1, which is considered to be the main scaffolding subunit of 
eIF3. The group of Dr. P.J. Lukavsky, our collaborators from MRC in Cambridge, 
recently solved an NMR solution structure of the human eIF3b-RRM and revealed 
that it creates a hydrophobic pocket to which human HCR1 sticks a critical Trp 
residue occurring in its N-terminal acidic region. I mutated the key residues of the 
“hydrophobic pocket” in yeast PRT1-RRM and showed that the mode of its 
interaction with HCR1 has remained evolutionary conserved. Furthermore, I also 
demonstrated that this contact is required for HCR1 association with the rest of eIF3 
in vivo and, most importantly, that the hydrophobic pocket greatly promotes binding 
of eIF3 itself to the 40S ribosomal subunit. To conclude, my results combined with 
data of our collaborators from NIH in Bethesda, namely from Dr. A.G. Hinnebusch’s 
group,  indicate that the TIF32-HLD, HCR1 and PRT1-RRM together constitute an 
eIF3 module that significantly stimulates its association with the 40S ribosomal 
subunit and co-ordinates the process of stringent selection of the AUG start codon. 
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Introduction 
 
 
Gene expression is a complex process by which the information encoded in 
individual genes is first transcribed into a nucleotide sequence of a messenger RNA 
(mRNA) and subsequently translated into a string of amino acids of a new 
polypeptide chain. This principal - the flow of genetic information from DNA to 
RNA to protein is called the central dogma of molecular biology.  
Gene expression is regulated at multiple levels. Compared to transcriptional 
regulation, translational control of existing mRNA’s allows for more rapid changes 
in concentration of the encoded proteins, it is critical for gene regulation during 
nutrient deprivation and stress, development and differentiation, aging and disease 
(reviewed in Sonenberg and Hinnebusch, 2009). Recently discovered potential for 
translational control of the mammalian genome by miRNAs is a fine example of its 
importance (Carthew and Sontheimer, 2009). 
 Translation takes place in cytoplasm where the mRNA associates first with 
small and then with large ribosomal subunits. It can be divided into four steps 
(initiation, elongation, termination and ribosome recycling) out of which the first step 
is the most critical as it serves as a target of many regulatory pathways.  
Cap-dependent translation initiation requires the participation of numerous 
proteins and protein complexes that are in eukaryotes called eukaryotic initiation 
factors (eIFs). Simply speaking, 12 eukaryotic eIFs orchestrate binding of methionyl 
initiator tRNA (Met-tRNAiMet) and mRNA to the small ribosomal subunit, in other 
words the assembly of 43S and 48S preinitiation complexes followed by scanning for 
the AUG start codon. There has been enormous progress over the last decade in 
revealing the molecular mechanisms of eukaryotic translation initiation (reviewed in 
Sonenberg and Hinnebusch, 2009).  
In Laboratory of Regulation of Gene Expression (LRGE), where this thesis was 
conducted, we are mostly interested in translation initiation factor 3 (eIF3), which 
represents by far the most complex initiation factor. In yeast S. cerevisiae, it is 
composed of 6 subunits (TIF32, PRT1, NIP1, TIF32, TIF35, HCR1) all of which 
have corresponding orthologs in mammalian eIF3 that contains additional 7 subunits 
(d, e, f, h, k, l, m) (reviewed in Hinnebusch, 2006). Given such a complexity, it is not 
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surprising that eIF3 was demonstrated to promote nearly all initiation steps including 
Met-tRNAiMet and mRNA binding to 40S ribosomal subunit, subsequent scanning of 
mRNA, and the start codon recognition.  
The aim of this work is to bring a closer insight into the functions of three 
subunits of eIF3, namely TIF32, PRT1 and HCR1, and molecular determinants of 
their interactions with each other and with the remaining eIF3 subunits. To achieve 
these goals I used the budding yeast S. cerevisiae as a model organism and a whole 
variety of molecular biology, genetic and biochemical techniques. 
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Review of previous research 
 
 
1. Translation initiation 
 
Translation initiation in eukaryotes is a complex series of reactions leading to 
the formation of an 80S ribosomal complex containing Met-tRNAiMet base paired to 
the AUG start codon in the ribosomal P-site. The main initiation pathway in 
eukaryotes is cap-dependent; ribosomes bind near the cap structure (m7GpppN) at the 
5‘ end of mRNA and then scan the mRNA in the 5‘ to 3‘ direction until they 
encounter an initiator AUG codon (Kozak M., 1989).   
The conventional view of the translation initiation pathway (Fig. 1) starts with 
the recruitment of the Met-tRNAiMet to the 40S ribosome to form 43S preinitiation 
complex. The Met-tRNAiMet is transferred to the 40S subunit bound by eIF2 in its 
GTP form to produce the ternary complex (TC), and the formation of 43S 
preinitiation complex is stimulated by the eIF3 complex, eIF5, eIF1 and eIF1A. The 
43S  preinitiation complex then binds to the capped 5‘ end of mRNA, with the help 
of the eIF4F, eIF4B, PABP, and eIF3 (Hershey and Merrick, 2000; Sachs and 
Varani, 2000; Marintchev and Wagner 2005). The resulting 48S complex scans the 
mRNA until the AUG start codon is recognized. Scanning is promoted by eIF1, 
eIF1A, and eIF4F in a mammalian reconstituted systems (Pestova and Kolupaeva 
2002), whereas yeast genetic data indicate that eIF3 and eIF5 also participate in vivo 
(Nielsen et al. 2004; Yamamoto et al. 2005). eIF5 stimulates partial GTP hydrolysis 
by eIF2 to GDP and Pi, but the Pi is not released from the scanning complex until the 
anticodon of Met-tRNAiMet base-pairs with the AUG start codon, which induces 
dissociation or displacement of eIF1 (Algire et al. 2005; Cheung et al. 2007). Met-
tRNAiMet is then released into the P-site and the 40S-Met-tRNAiMet-mRNA initiation 
complex is joined by the 60S ribosomal subunit in a reaction stimulated by GTP-
bound eIF5B (Pestova et al., 2000) to form an 80S initiation complex that becomes 
poised for elongation. Subunit joining is thought to facilitate ejection of all eIFs but 
eIF1A (Unbehaun et al. 2004) and eIF3 (Szamecz et al. 2008). For a new round of 
initiation, the ejected eIF2-GDP must be recycled to eIF2-GTP by the guanine 
nucleotide exchange factor eIF2B (Hershey and Merrick, 2000; Hinnebusch, 2000). 
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 FIGURE 1. Translation initiation pathway. (Valášek et al., unpublished data) 
 
 
Experiments with the yeast Saccharomyces cerevisiae revealed that translation 
initiation in this lower eukaryote strongly resembles cap-dependent initiation in 
mammals. This is perhaps most convincingly demonstrated by finding that some 
mammalian initiation factors can substitute for yeast factors in vivo (Schwelberger et 
al., 1993). Numerous key studies that were conducted with this ideal model organism 
since early 80s have contributed by a great deal to our understanding of this 
fundamental process. 
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2. The eIF3 complex 
 
Eukaryotic translation initiation factor 3 (eIF3) was one of the first initiation 
factors to be identified in the 1970s, but it is only in the past decade that much of our 
knowledge about how eIF3 functions at the molecular level has been gained. 
Evidence now indicates that most of the reactions in the initiation pathway are 
stimulated by eIF3 (Hinnebusch, 2006).  
eIF3 is a large multisubunit protein complex that plays an essential role in the 
binding of Met-tRNAiMet and mRNA to 40S ribosomal subunit, and also in the 
subsequent scanning and AUG recognition. It can bind directly to the 40S ribosome 
(Kolupaeva et. al., 2005), is involved in the dissociation of the 80S ribosome to 40S 
and 60S subunit (Kolupaeva et al., 2005) and is also required for the process of 
reinitiation (Szamecz et al. 2008). 
Consistent with its diverse functions, mammalian eIF3 has the most complex 
structure of the initiation factors, containing 13 non-identical subunits that are 
designated eIF3a to eIF3m (Asano et al., 1997; Vornlocher et al., 1999; Browning et 
al., 2001; Hinnebusch, 2006 ) (Tab. 1). 
By contrast, eIF3 from the yeast Saccharomyces cerevisiae is much simpler, 
the core of eIF3 is thought to be composed of five essential subunits: eIF3a/TIF32 
(RPG1), eIF3b/PRT1, eIF3c/NIP1, eIF3i/TIF34 and eIF3g/TIF35 (Asano et al. 
1998). All of them have homologues in the mammalian eIF3 complex. Only one 
additional mammalian eIF3 subunit (eIF3j) has a homolog encoded in the 
Saccharomyces cerevisiae genome. This protein, called HCR1, is a non-essential 
substoichiometric subunit of yeast eIF3 that enhances interactions with other eIFs, 
promotes binding of eIF3 to the 40S subunit and has an independent function in 40S 
ribosome biogenesis (Valášek et al., 2001a,b; Nielsen et al., 2006). 
Importantly, the 5-subunit complex purified from yeast can restore binding of 
Met-tRNAiMet (Danaie et al., 1995; Phan et al., 1998) and mRNA (Phan et al., 2001) 
to 40S ribosomes in heat-inactivated prt1-1 mutant extracts. Thus, yeast eIF3 
possesses two critical functions ascribed to the more complex mammalian factor. 
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TABLE 1. Summary of eIF3 subunits in selected eukaryotes (Hinnebusch, 2006) 
Unified  Homo sapiens 
Schizosaccharomyces 
pombe 
Saccharomyces 
cerevisiae  Functions  
nomenclature      
eIF3a p170 p107 TIF32 
40S binding; 
eIF4B binding; 
MFC assembly; 
TC and  
    mRNA 
recruitment  
eIF3b p116 p84 PRT1 
40S binding; MFC 
assembly; TC and 
mRNA  
    recruitment; 
scanning  
 
eIF3c p110 p104 NIP1 
40S binding; MFC 
assembly; TC and 
mRNA  
    recruitment; AUG 
recognition  
eIF3d p66 Moel –  
eIF3e p48 Int6 –  
eIF3f p47 Csn6 –  
eIF3g p44 TIF35 TIF35 Binding eIF4B  
eIF3h p40 p40 –  
eIF3i p36 Sum1 TIF34  
eIF3j p35 – HCR1 40S binding; MFC assembly  
eIF3k p28 – –  
eIF3l p67 – –  
eIF3m GA17 Csn7B –  
 
 
2.1 Interactions of eIF3 with other eIFs and with 40S subunit 
 
eIF3 is physically associated with other eIFs in yeast. It interacts directly with 
eIF5, eIF2, and eIF1 and these interactions may contribute to the stimulatory effect 
of eIF3 in binding of eIF1 and TC to the 40S subunit observed in vitro (Hinnebusch, 
2000; Kolupaeva et al., 2005; Jivotovskaya et al., 2006; Nielsen et al., 2006). 
Two interactions between yeast eIF3 and eIF2 have been described so far; a 
direct interaction between eIF2β and TIF32 and an indirect interaction between 
eIF2β and NIP1 that is bridged by eIF5. In addition to binding eIF5, NIP1 also 
interacts with eIF1, which additionally interacts with eIF5, TIF32 and 
eIF2β. Interestingly, both eIF5 and eIF1 were implicated in selecting AUG as the 
start codon, and their related functions in scanning may be coordinated by mutual 
association with NIP1 (Asano et al., 2000; Algire et al., 2002; Valášek et al., 1999, 
2002; Nielsen et al., 2006), (see Fig. 2). 
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Studies in budding yeast have shown that deleting the N and C termini of NIP1 
or the TIF32 N-terminal domain (TIF32-NTD) impairs 40S binding by otherwise 
intact eIF3 complexes, suggesting that these segments contact the 40S subunit. 
Indeed, a subcomplex consisting of NIP1, the N-terminal half of TIF32, and eIF5 can 
bind the 40S subunit in vitro and in vivo. The TIF32 C-terminal domain (TIF32-
CTD) is also required for 40S binding when the connection between eIF3 and eIF5 is 
disrupted by mutation. In addition, a putative RNP1 element in the RNA recognition 
motif (RRM) present in PRT1-NTD mediates a protein-protein interaction with 
HCR1, and both the RNP1 element and HCR1 are required for wild-type 40S 
binding by eIF3. Thus there are probably many contacts between the 40S subunit and 
the different eIF3 subunits (Nielsen et al., 2006; Hinnebusch, 2006). 
 
FIGURE 2. A 3D model of the MFC (Valášek et al. 2002) 
 
 
3. Yeast Multifactor complex 
 
As aforementioned, yeast eIF3 and eIF1 reside with the TC and with eIF5 in a 
ribosome-free multifactor complex (MFC) (Fig. 2.) (Asano et al., 2000), that is 
thought to exist as a preformed unit in cytoplasm and be capable of cooperative 
binding to 40S ribosomes at once (Valášek et al., 2002, 2003, 2004; Asano et al., 
2001; Nielsen et al., 2006; Jivotovskaya et al., 2006; Yamamoto et al., 2005; Singh et 
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al., 2004). As such it was proposed to represent an important intermediate in 
translation initiation (Hinnebusch, 2006). Indeed, the integrity of the MFC was 
shown to be required for optimal rates of translation initiation in vivo as destabilizing 
mutations in its individual components affected TC and mRNA binding to 40S 
subunits as well as the post-assembly reactions such as scanning and AUG 
recognition (Valášek et al., 2002; Nielsen et al., 2004). The importance of MFC 
integrity for 43S assembly in yeast is also evident from experiments in which 
mutations in eIF5, TIF32, NIP1, or eIF1 led to reduced 40S binding in vivo of not 
only the mutated factor but also other MFC constituents (Asano et al., 2001; Nielsen 
et. al., 2004; Singh et. al., 2004). 
   
 
4. The PRT1 subunit of eIF3 
 
PRT1 is a 90kDa subunit of eIF3 homologous to the mammalian p116 subunit. 
Yeast PRT1 was identified by complementation of one of the original Hartwell’s 
temperature sensitive CDC mutants, cdc63/prt1-1, and it was the first gene encoding 
a protein involved in the initiation of protein synthesis in any eukaryotic organism to 
be isolated (Keierleber et al. 1986).  
Among the components of eIF3, PRT1 is considered to be the major 
scaffolding subunit within the eIF3 complex, interacting with all other eIF3 subunits 
such as TIF32, TIF35, TIF34 and HCR1. PRT1 is an essential subunit and contains 
an N-terminal RNA recognition motif (RRM), which is crucial for the integrity of the 
eIF3 complex and important for 40S subunit binding (Valášek et. al., 2001a; Nielsen 
et. al., 2006) (see Figure 3. for schematic interaction map). Studies using deletion 
mutations in individual eIF3 subunits and yeast two hybrid analysis showed that the 
RRM in PRT1 interacted simultaneously with TIF32 and HCR1 (Asano et al., 1998; 
Valášek et al., 2001a). Removal of the RRM domain in PRT1 resulted in dissociation 
of TIF32, NIP1 and HCR1 from the eIF3 complex and destroyed the 40S ribosomal 
subunit binding by the residual PRT1-TIF35-TIF34 subcomplex (Valášek et. al., 
2001a).  
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FIGURE 3. Schematic of PRT1 with arrows delimiting minimal binding domains for indicated 
proteins. RRM domain and position of prt1-1 mutation are indicated (Valášek, unpublished data). 
 
 
The solution structure of the RRM of human homolog of PRT1 (eIF3b-RRM) 
was determined by NMR spectroscopy. The structure reveals a noncanonical RRM 
with a negatively charged surface in the beta-sheet area contradictory with potential 
RNA binding activity (Fig. 4.) (ElAntak et. al., 2007).  
 
 
FIGURE 4. Solution structure of the human eIF3b-RRM (residues 185-264 are displayed). Ribbon 
diagram of the eIF3b-RRM structure. The secondary structure elements are numbered. Adapted from 
(ElAntak et. al., 2007) 
 
 
C-terminal domain of PRT1 does not contain any recognizable domain or 
motif, nevertheless, it is critical for the PRT1 function because it anchors two other 
essential subunits of unknown function, TIF35 and TIF34 (Asano et al. 1998; 
Valášek et al. 2001a). The binding site for NIP1 is located just upstream from the 
TIF34-TIF35 binding site at the extreme C-terminus of PRT1. Residues 371-570 of 
NIP1 contain a binding site for PRT1 that is required for tight association of the 
PRT1-TIF34-TIF35 subcomplex with other eIF3 subunits (Valášek et al., 2002). 
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5. The TIF32 subunit of eIF3 
 
TIF32, the largest subunit of eIF3, is an essential protein with a calculated 
molecular mass of approximately 110kDa. The Saccharomyces cerevisiae TIF32 is 
the sequential and functional homologue of the mammalian p170 subunit with 29% 
identity and 54% similarity between their amino acid sequences (Valášek et al., 
1998). 
It was originally described as an essential protein being required for passage 
through the G1 phase of the cell cycle. Elutriated cells of the temperature sensitive 
rpg1-1 mutant arrested in the early G1 phase of the first cell cycle and ceased cell 
growth when shifted to restrictive conditions (Kovarik et al., 1998).  
It was shown that the TIF32 protein is required for translation initiation in vivo 
and in vitro and interacts with the PRT1 subunit of eIF3 (Valášek et al., 1998). 
Involvement of TIF32 in the process of translation initiation was clearly 
demonstrated in a cell-free system dependent on exogenous eIF3 (Altmann et al., 
1997): the sucrose gradient fraction containing TIF32 possessed the biochemical 
activity ascribed to eIF3, e.g. the restoration of translation in an extract in which an 
endogenous eIF3 subunit had been inactivated. In addition to PRT1, TIF32 has been 
also shown to interact with NIP1 (Asano et. al., 1998), with HCR1 (Valášek et al., 
1999) and, as described in detail thereinafter, with 40S ribosomal subunits (Valášek 
et al., 2003) (see Figure 5. for schematic interaction map). 
 
 
 
FIGURE 5. Schematic of TIF32 with arrows delimiting minimal binding domains for indicated 
proteins. HCR1-like domain (HLD) and position of rpg1-1 mutation are indicated (Valášek, 
unpublished data). 
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5.1 Interactions of TIF32 with PRT1 RRM and HCR1 
 
The HCR1-like domain (HLD) of TIF32 (see below) is sufficient, but not 
absolutely required for TIF32 binding to the RRM domain in PRT1. TIF32 can bind 
to the RRM domain of PRT1 through its HLD or C-terminus (Valášek et al. 2001a). 
The interaction between TIF32 and the RRM domain of PRT1 is conserved in the 
human homologues of TIF32 (p170) and PRT1 (p116) (Methot et al., 1997). In 
addition, HCR1 makes multiple contacts with TIF32-CTD indicating a network of 
physical interactions involving TIF32, HCR1 and PRT1 RRM where HCR1 probably 
serves to stabilize or modulate the interaction between TIF32 and PRT1 RMM which 
is crucial for integrity of the MFC and its association with 40S ribosomes (Valášek et 
al. 2001a). 
 
5.2 Interactions of TIF32 with 40S ribosomes 
 
As already mentioned above, deletion of the extreme N-terminus of TIF32 led 
to nearly complete abolishment of 40S binding by eIF3, suggesting that the TIF32-
NTD plays a crucial role in association of the MFC with the 40S ribosomes. Since its 
removal had a minimal impact on MFC composition, it seems likely, that the TIF32-
NTD may interact directly with the 40S ribosomes. Consistent with this idea, it was 
discovered, that the TIF32-NTD strongly interacts with the C-terminal domain of 
40S ribosomal protein RPS0A and with RPS10A (Valášek et al., 2003, Szamecz et 
al., 2008). 
RPS0A is expected to reside on the solvent side of the 40S subunit (opposite to 
the 60S-interface side), between the protuberance (pt) and beak (bk). Hence, binding 
of TIF32-NTD to RPS0A would place this portion of eIF3 on the solvent side of the 
40S ribosome (Fig.6C). 
In addition, it was shown that the extreme CTD of TIF32 is also critical for 40S 
binding in the presence of a mutant form of eIF5 that interferes with integrity of the 
MFC. Further studies have shown that the TIF32-CTD specifically interacts with 18S 
rRNA. The yeast 18S rRNA can be divided into three domains based on its tertiary 
structure, with domain I forming the body (b) and shoulder (sh) of the 40S ribosome, 
domain II forming the protuberance (pt), and domain III forming the head (h), beak 
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(bk), and common core (helix 44) of the 40S subunit (Spahn et al. 2001). To 
investigate which domain mediates the interaction between 18S rRNA and the 
TIF32-CTD, three RNA transcripts corresponding to isolated domains I, II, and III 
were tested for TIF32-CTD binding. Only domain I, in particular, a short segment 
spanning helices 16-18 showed specific interaction with TIF32-CTD (Valášek et al., 
2003). 
Whereas the TIF32-NTD – RPS0A interactions places the main body of eIF3 
on the solvent head side of the 40S ribosome, the interaction observed between the 
TIF32-CTD and 18S rRNA would provide eIF3 with access to the 60S-interface side. 
Helices 16 and 18 are accessible from both sides of 40S subunit, and helix 16 
protrudes into the solvent. If the TIF32-CTD wraps around helix 16, it would be 
exposed on the interface side of the 40S subunit (Fig 6D). Thus eIF3 binds to the 
solvent side but has access to the 60S-interface side of the 40S ribosome (Valášek et 
al., 2003). 
 
 
FIGURE 6. Model predicting the interaction of eIF3 with the Saccharomyces cerevisiae 40S 
ribosomal subunit. (A, B) Cryo-EM reconstruction of the S. cerevisiae 40S subunit docked with 
modified atomic models of 18S rRNA and 40S ribosomal proteins, adapted from Spahn et al. (2001). 
The 40S subunit is shown from the solvent (A) or interface (B) sides, with RNA segments in yellow 
or turquoise and proteins in green. (C, D) Hypothetical location of the eIF3 complex on the 3D model 
of the 40S subunit based on the results of (Valášek et al., 2003). 
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The location of eIF3 on the solvent side of the 40S makes it an ideal landing 
pad for regulatory factors that must be targeted to the initiation complex without 
interfering with the mechanics of initiation on the interface surface. It might also 
permit interactions with mRNA that wraps around the back of the 40S subunit 
(Hinnebusch, 2006). 
 
 
6. HCR1 (high copy suppressor of RPG1) 
 
HCR1 protein was originally isolated as a high copy suppressor of temperature 
sensitive (Ts-) phenotype of the rpg1-1 allele of TIF32, encoding the largest subunit 
of yeast eIF3. This high dosage HCR1-driven complementation is rpg1-1 allele 
specific; HCR1 is not able to functionally replace TIF32. Functional relationship 
between the latter proteins was, however, further illustrated by the fact that 
combining the hcr1Δ allele with rpg1-1 exacerbated the growth defect conferred by 
rpg1-1 (Valášek et al., 1998, 1999). 
HCR1 is a non-essential substoichiometric subunit of eIF3, no more than a 
quarter of the total eIF3 complexes contain HCR1 and it is less tightly associated 
with the eIF3 than are the five core subunits (Valášek et al., 2001a).  It represents the 
S. cerevisiae homologue of the p35 subunit of human eIF3, sharing 26% identity and 
42% similarity with its human orthologue (Fig 7.) (Valášek et al., 1999). 
 
 
FIGURE 7. Sequence comparison between HCR1 and the p35 subunit of human eIF3.  
(Valášek et al., 1999) 
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Deletion of HCR1 led to a slow growth (Slg-) phenotype and produced 
abnormalities in the polysome profile – an obvious decrease in the portion of large 
polysomes, indicating a reduced rate of translation initiation. It also reduced the 
amounts of eIF2 and eIF5 (by ~ 30%) and the amount of eIF1 (by ~ 75%) that 
coimmunoprecipitated with eIF3, suggesting that HCR1 has a significant effect on 
the formation and stability of the MFC (Valášek et al., 2001a). Deletion of HCR1 
also reduced the 40S association of eIF3 core subunits, suggesting that HCR1 
contributes to 40S binding by yeast eIF3 in vivo (Nielsen et al., 2006). 
Mammalian homolog of HCR1, p35/eIF3j, is the most important eIF3 subunit 
for forming a stable eIF3-40S complex, it promotes the stable association of eIF3 
subcomplexes to the 40S ribosomal subunit and binds specifically to the 40S 
ribosomal subunit in vitro (Fraser et al., 2004). 
 
6.1 Function of HCR1 in ribosome biogenesis 
 
Deletion of HCR1 also led to a striking reduction in the abundance of free 40S 
subunits and a corresponding increase in free 60S subunits, suggesting that HCR1 is 
required for the biogenesis or stability of 40S ribosomes (Valášek et al., 2001a). 
There is also evidence that HCR1 can interact with 40S ribosomes independently of 
eIF3 and other components of the MFC (Phan et al., 2001).  
HCR1 is localized predominantly in the cytoplasm, consistent with a role in the 
final steps of 40S biogenesis occurring in this compartment. It is required for a wild-
type rate of processing of 20S pre-rRNA to mature 18S rRNA - it is an RNA binding 
protein, it binds to 20S pre-rRNA in the nascent 40S subunit and directly influences 
the efficiency of cleavage at the D processing site (Valášek et al., 2001b). 
 
6.2 Interactions of HCR1 
  
A network of interactions physically links HCR1 to the two largest subunits of 
eIF3, TIF32 and PRT1. HCR1 binds to an RNA recognition motif (RRM) in PRT1 
N-terminal domain and makes multiple contacts with TIF32 C-terminal domain. 
HCR1 and TIF32 can bind simultaneously to the PRT1 RRM (Valášek et al. 2001b).  
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Based on unpublished observations from the group of our collaborator P. J. 
Lukavsky, a human homolog of HCR1, eIF3j, specifically binds to the hydrophobic 
pocket formed by helix α1 (α1) and loop 5 (L5) of the human eIF3b-RRM (Fig. 8) 
by its N-terminal acidic motif centered by the conserved tryptophan (Trp52) residue 
(L. ElAntak and P.J. Lukavsky, unpublished observations). 
   
 
 
 
 
 
 
 
 
FIGURE 8. Surface representation of the contacts between human eIF3j peptide and human eIF3b-
RRM. Green and blue surfaces indicate hydrophobic and basic eIF3b-RRM residues, respectively. 
Basic residues are labelled. eIF3j peptide is shown as a ribbon ball-and-stick representation, and most 
of its residues are numbered with primed numbers. The lowest-energy structure of eIF3b-RRM bound 
to eIF3j peptide is shown. (L. ElAntak and P.J. Lukavsky, unpublished observations). 
 
 
 
As mentioned above, HCR1 and its human homologue eIF3j can interact with 
40S ribosome on its own. Through its CTD, eIF3j binds directly in the mRNA entry 
channel and aminoacyl (A) site, placing eIF3j on the 40S subunit interface (Fraser et 
al., 2007). Notably, the C-terminal 16 amino acids of eIF3j are required for its high 
affinity for the 40S subunit, as cleavage with caspase-3 reduces the association of 
eIF3j with the 40S subunit in vitro (Fraser et al., 2004). 
 
6.3 Sequence similarity between TIF32 and HCR1 
 
The fact that both TIF32 and HCR1 interacted with the RNA recognition motif 
(RRM) in PRT1 prompted an idea that both protein could share a similar binding 
motif. Thus TIF32 and HCR1 sequences were aligned and it was discovered that 
residues 490-790 in TIF32 are 25% identical to the entire sequence of HCR1 (Fig. 
9.). This internal segment of TIF32 was thus named HLD (the HCR1-like domain) 
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(Valášek et al., 2001a). Interestingly, the Ts- phenotype of the rpg1-1 allele of TIF32 
is conferred by a single aminoacid substitution of arginine to isoleucine at position 
731 (Valášek et al., 1998) that falls into the C-terminal segment of the HLD of 
TIF32. Strikingly, this arginine residue is conserved in the HCR1 sequence at 
position 215 (Fig. 9.) and, moreover, corresponds to the most C-terminal residue of a 
K-x5-ER-x2-R (KERR) motif that is completely conserved among Saccharomyces 
cerevisiae HCR1 and all known TIF32 orthologs (Fig. 10.). A similar motif K-x3-
EK-x2-K (KEKK) also occurs in human eIF3-p35 (Valášek et al., 2001a). 
   
 
FIGURE 9. Sequence comparison between full-length HCR1 and the HLD of TIF32. (Valášek et al., 
unpublished data) 
 
 
 
 
FIGURE 10. Multiple sequence alignment. The K-x5-ER-x2-R motif is conserved among TIF32 and 
HCR1 orthologs in various species. (Valášek et al., unpublished data) 
 
 
To explore the physiological significance of the sequence similarity between 
HCR1 and TIF32, the hcr1-R215I mutant was made by substitution of arginine in 
position 215 with isoleucine. Strikingly, this mutation eliminated suppression of 
rpg1-1 mutant, which is suppressible by wild-type HCR1 in high copy. Since the 
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hcr1-R215I allele fully complemented the slow growth phenotype of hcr1Δ strain 
when expressed on a single copy number plasmid, it can not be classified as a null 
allele. Thus the R215I substitution alters the function of HCR1 in a manner that 
influences its ability to compensate for defects in TIF32 when overexpressed. The 
fact that mutating the equivalent amino acids in HCR1 and the HLD of TIF32 altered 
the functions of both proteins in vivo supports the physiological relevance of 
sequence similarity between HCR1 and TIF32 (Valášek et al., 2001a). 
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Material and methods 
 
 
7. Laboratory equipment 
 
7.1 Centrifuges 
 
Beckman Coulter Allegra® X-15R Centrifuge, rotor SX 4750A 
Beckman Coulter optimaTML-90K Ultracentrifuge, rotor SW 41 
Biosan Centrifuge/vortex Multi Spin MSC-300 
Eppendorf Centrifuge 5414D 
 
7.2 Electrophoresis 
 
Bio-Rad Criterion Cell  
Bio-Rad Mini-Sub Cell GT Cell 
Bio-Rad Wide-Sub Cell GT Cell 
Bio-Rad PowerPac Basic power supply   
Bio-Rad PowerPac HC power supply  
Bio-Rad PowerPac Universal power supply  
 
7.3 Other  equipment 
 
Beckman Coulter DU®530 Life Science UV/VIS Spectrophotometer 
BioComp Gradient Master 
Bio-Rad Gene Pulser Xcell Electroporation System 
Biosan  Bio RS-24 Rotator 
Biosan Mini Rocker MR-1 
Biosan Multi RS-60 Rotator 
Brandel BR-188 Density Gradient Fractionation System 
Eppendorf Mastercycler ep gradient S 
Eppendorf Thermomixer Comfort 
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Syngene G:BOX iChemi – gel documentation and analysis system 
Multitron INFORS HT shaker 
Scientific Industries Vortex genie 2 
Thermo Scientific SGD2000 Slab Gel Dryer 
 
 
8. Chemicals 
 
10x TBE (Bio-Rad) 
10x TBS (Bio-Rad) 
10x TG (Bio-Rad) 
10x PBS (Bio-Rad) 
Agar (Serva) 
Bacto Peptone (Becton, Dickinson and Company) 
Bacto Tryptone (Becton, Dickinson and Company) 
Bacto Yeast Extract (Becton, Dickinson and Company) 
Bio-Rad Protein Assay Kit (Bio-Rad) 
Bromophenol Blue (Sigma) 
β-Mercaptoethanol (Sigma) 
Complete Protease Inhibitor Mix tablets (Roche) 
Criterion Precast Gels, 4-20% Tris-HCl, 1mm, 12+2 Well Comb, 45 μl (Bio-Rad) 
D-glucose (Lachner) 
ECLTM Anti Rabbit IgG, HRP-linked whole antibody (from donkey) (GE Healthcare) 
EDTA (Sigma) 
EDTA-free Complete Protease Inhibitor Mix tablets (Roche) 
Electroporation cuvettes (Eppendorf) 
EP-MAXTM 10B Competent Cells (Bio-Rad) 
Ethidium bromide (Serva) 
Gel Code® Blue Stain Reagent (Thermo Scientific) 
Glutathione SepharoseTM 4B (GE Healthcare) 
HEPES (Serva) 
Imidazole (Fluka) 
Igepal CA-630 (Sigma) 
 27
Lithium acetate dihydrate (Sigma) 
Ni-NTA silica (Qiagen) 
PEG (Fluka) 
PMSF (Serva) 
SDS solution 20% (Sigma) 
SeaKem® LE Agarose (Lonza) 
Sodium Floride (Fluka) 
Subcloning EfficiencyTM DH5αTM Competent Cells (Invitrogen) 
Sucrose (Fluka) 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific) 
Tris (Serva) 
Triton X-100 (Sigma) 
Tween 20 (Sigma) 
 
 
9. Solutions 
 
B buffer for GST pull-downs: 20mM HEPES (pH 7,5); 75mM KCl; 0,1mM 
EDTA; 2,5mM MgCl2; 0,05% IGEPAL 
BB buffer for Nickel affinity purification: 20 mM Tris-HCl (pH 7,5); 100 mM 
KCl; 5 mM MgCl2; 0,5 mM β-ME; 1mM PMSF; 20 mM imidazole; 10% (v/v) 
glycerol, 1 x EDTA-free Complete Protease Inhibitor Mix tablets 
Blotting buffer (1000 ml for 1 blotting): 700 ml dH2O; 200 ml methanol; 100 ml 
10xTG 
E buffer: 20mM Tris-HCl (pH 7,5); 100 mM KCl; 5mM MgCl2; 0,5 mM β-ME; 
1mM PMSF; 250 mM imidazole; 10% (v/v) glycerol, 1 x Complete Protease 
Inhibitor Mix tablets 
GA solution: 20mM Tris-HCl (pH 7,5); 50 mM KCl; 10 mM MgCl2 
GB solution: 20mM Tris-HCl (pH 7,5); 50 mM KCl; 10 mM MgCl2; 45% sucrose 
GF buffer: 25 ml GA; 5mM NaF; 1mM DTT; 1mM PMSF; 1 μg/ml Aprotinin; 1 
μg/ml Leupeptin; 1 μg/ml Pepstatin; 1 tablet of Complete EDTA-free Protease 
Inhibitor Mix 
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Sample buffer for agarose gel electrophoresis 6x: 30% glycerol; 0,25% 
bromophenol blue 
Sample loading buffer for SDS-PAGE 4x: 1M Tris-HCl (pH 6,8); 40% glycerol; 
8% SDS; 0,06% bromophenol blue; 1,47% β-ME 
SDS-Loading Buffer 6x: 3,3 ml 1 M Tris (pH 7,5); 6 ml glycerol; 1,2 g SDS; heat 
up and add 150 μl β-ME and a little bit bromophenol blue 
SDS-PAGE running buffer: 1xTG; 0.1% SDS 
TBS-T buffer: 1x TBS; 0,1% Tween 20 
 
 
10. Saccharomyces cerevisiae strains 
 
Strain Genotype Plasmid Source 
H423 MATa, leu2-3, -112, ura3-52, trp1, gcn2-
del’, tif32-del’ (TIF32, URA3) 
TIF32, AmpR, 
URA3 
Klaus Nielsen 
H425 MATa, leu2-3, -112, ura3-52, trp1, gcn2-
del’,  prt1 (PRT1, URA3) 
PRT1, AmpR, URA3 Klaus Nielsen 
H428 MATa, PRT1, leu2-3, -112, ura3-52, hcr1Δ NONE Klaus Nielsen 
 
 
11. Escherichia coli strains 
 
Strain Genotype Source 
DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17  
Invitrogen 
BL21 B F- dcm ompT hsdS(rB- mB-) galλ(DE3) 
 
Stratagene 
 
 
12. Plasmids 
 
Plasmid Description Source or 
reference 
YEpLVHCR1 Wt HCR1 on high copy LEU2 plasmid from 
YEplac181; AmpR 
Valášek et al. 1999 
YEpHCR1-DS HCR1 with artificial BamHI and NcoI sites 
introduced before AUG and the stop codon, 
respectively on high copy LEU2 plasmid 
from YEplac181; AmpR 
This study 
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pRSTIF32-His C-term His8 tagged TIF32 on low copy 
LEU2 plasmid from pRS315; AmpR 
Valášek et al. 2002 
pRSTIF32-His-DS C-term His8 tagged TIF32 with artificial 
BamHI and NcoI site introduced before and 
after the HLD domain on low copy LEU2 
plasmid from pRS315; AmpR 
This study 
YEpHLD TIF32's HLD placed under the HCR1 
promoter using BamHI-NcoI artificial sites 
on high copy LEU2 plasmid from 
YEplac181; AmpR 
This study 
pRSTIF32-HCR1-His TIF32 with HLD replaced by HCR1 using 
BHI-NcoI artificial sites on low copy LEU2 
plasmid from pRS315; AmpR 
This study 
YCpTIF32-His C-term His8 tagged TIF32 on single copy 
URA3 plasmid from YCplac33; AmpR 
Valášek et al. 2003 
pRS315 low copy cloning vector, LEU2 ; AmpR Sikorski and Hieter 
1989 
YEplac181 high copy cloning vector, LEU2; AmpR Gietz and Sugino 
1988 
pRSPRT1-His-XS C-term His8 tagged PRT1 on low copy 
LEU2 plasmid from pRS315; AmpR 
This study 
pKHN45 (= 
pRSPRT1-His) 
C-term His8 tagged PRT1 on low copy 
LEU2 plasmid from pRS315; AmpR 
Nielsen et al. 2006 
pRSPRT1-AALA-His C-term His8 tagged PRT1 containing AALA 
mutation on low copy LEU2 plasmid from 
pRS315; AmpR 
This study 
pRSPRT1-LFSK-His C-term His8 tagged PRT1 containing LFSK 
mutation on low copy LEU2 plasmid from 
pRS315; AmpR 
This study 
pRSPRT1-α1L5-His C-term His8 tagged PRT1 containing α1L5 
mutation on low copy LEU2 plasmid from 
pRS315; AmpR 
This study 
pT7-7 Contains the T7 RNA polymerase promoter 
for in vitro transcription and translation; 
AmpR 
Tabor and 
Richardson 1987 
pT7-prt1-rrm (ΔA) PRT1[1-136]ORF cloned under T7 
promoter 
Valášek et al. 
2001a 
pT7-prt1-rrm-AALA PRT1[1-136]ORF containing AALA 
mutation cloned under T7 promoter 
This study 
pT7-prt1-rrm-LFSK PRT1[1-136]ORF containing LFSK 
mutation cloned under T7 promoter 
This study 
pT7-prt1-rrm-α1L5 PRT1[1-136]ORF containing α1L5 
mutation cloned under T7 promoter 
This study 
pGEX-5x-3 GST fusion expression vector; AmpR Smith and Johnson 
1988 
pGEX-HCR1 GST-HCR1 fusion plasmid from pGEX-5x-
3; AmpR 
Valášek et al. 
2001a 
CR52 wt PRT1 on single copy URA3 plasmid Cigan et al. 1991 
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13. Oligonucleotides 
 
Name Sequence (5´ to 3´) 
DS HCR1-BHI CAAAAAAAAAAAAGTAATAAAAGGATCCATGTCTTGGGACGA 
CGAAGC 
DS HCR1-NcoI TTCGGTGATGACGACTTTATGCCATGGTAATCTGCTTATTGTTTC 
TTTGC 
DS TIF32-BHI GATTATGTTTCAATTACCATCGGATCCATGGATCATGAATCTGCT 
AAGGTTACA 
DS TIF32-NcoI ATGGTCTATGATGATTATTTGCCATGGAAGTTCAAGGAGCATGTT 
TCG 
AH-PRT1-BamHI TCACTTGGGATCCATCTGGTA 
AH-PRT1-NotI-R ATATGCGGCCGCGGATCTTTAGTGGTGGTGGTGGTGGTGGTGGT 
AH-PRT1-ApaI GGTACCGGGCCCCCCCTC 
LV-RRM-AALA-R TGCTTTTAAATCCAGTCTTTTACC 
LV-RRM-AALA GGTAAAAGACTGGATTTAAAAGCAGCTTTGGCACTTTATACTATG 
AAAGATGTT 
AH-PRT1-XbaI-R AGTTCTCTCTAGATTCCACCA 
AH-PRT1-A1B-R AGAAGTCAAAGCCTTTTTCAAAAC 
AH-PRT1-A1B GTTTTGAAAAAGGCTTTGACTTCTGCAGCAGCTGAAGCTGGTAAA 
GTTGTTAACATGGAA 
LVPNDEI-724 CCACGCATATGACTACCGAGACTTTCGAA 
LVPC136-724 CCTAAAAGCTTGAATTCGGTGTCAAAGTCGTC 
 
 
14. Cultivation media 
 
14.1 Bacterial cultivation media and plates 
 
LB medium : 10 g/l Bacto tryptone; 5 g/l Bacto yeast extract; 5 g/l NaCl (if needed 
add Ampicilin to final concentration 150 μg/ml). 
LB/Amp plates: 10 g/l Bacto tryptone; 5 g/l Bacto yeast extract; 5 g/l NaCl; 25 g/l 
agar; Ampicilin to final concentration 50 mg/ml. 
SOC medium: 20 g/l Bacto tryptone; 5 g/l Bacto yeast extract; 0,6 g/l NaCl; 0,2 g/l 
KCl; 3,5 g/l glucose. 
 
14.2 Yeast cultivation media and plates 
 
YPD medium: 20g/l Bacto peptone, 10g/l Bacto yeast extract, 20g/l glucose 
YPD plates: 20g/l Bacto peptone, 10g/l Bacto yeast extract, 20g/l glucose, 25g/l agar 
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SD medium: 1,45g/l YNB (yeast nitrogen base without AA and ammonium sulfate), 
5g/l ammonium sulfate, 20g glucose 
SD plates: 1,45g/l YNB (yeast nitrogen base without AA and ammonium sulfate), 
5g/l ammonium sulfate, 20g glucose, 25g/l agar 
5-FOA plates: 1,44g/l YNB (yeast nitrogen base without AA and ammonium 
sulfate), 5g/l ammonium sulfate, 20g glucose, 25g/l agar, 20mM uracil, 1g/l 5-FOA 
 
 
15. Bacterial and yeast cultivation 
 
15.1 Bacterial cultivation 
 
Bacteria were grown in liquid media at 37°C while shaking or on agar plates at 
37°C in incubator. 
 
15.2 Yeast cultivation 
 
Yeast were grown in liquid media at 30°C while shaking or on agar plates at 
30°C in incubator. Temperature sensitivity was tested at 37°C. 
 
15.3 Strain storage 
 
Bacterial strains were stored for short terms on agar plates at 4°C, for long 
terms at -80°C in 40% glycerol. Yeast strain were stored for short terms on agar 
plates at 4°C, for long terms at -80°C in 20% glycerol. 
 
15.4 Doubling time calculation 
 
 Doubling time was calculated for specific strains in this study according to 
formula: [ln(2)/ln(ODEND/ODBEGIN)]*time of growing 
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16. DNA manipulation 
 
16.1 Plasmid DNA isolation - QIAprep Spin Miniprep Kit (Qiagen) 
 
The miniprep procedure is based on alkaline lysis of bacterial cells followed by 
adsorption of DNA onto silica membrane in the presence of high salt. Bacteria are 
lysed under alkaline conditions, and the lysate is subsequently neutralized and 
adjusted to high-salt binding conditions. DNA is adsorbed onto silica membrane 
while RNA, cellular proteins and metabolites are not retained on the membrane but 
are found in the flow-through. 
 
Kit contains: QIAprep Spin Columns, Buffer P1, Buffer P2, Buffer N3, Buffer PB, 
Buffer PE, RNase A 
Protocol: 
- inoculate E. coli cells bearing plasmid of your interest into 2 ml of LB/Amp 
medium and grow them over night 
- pellet the cells by centrifugation at 13000 rpm for 30 seconds 
- resuspend the pellet in 250 μl Buffer P1 (containing RNase A) and transfer to 
a microcentrifuge tube 
- add 250 μl Buffer P2 (lysis buffer) and mix thoroughly by inverting the tube 
4-6 times 
- add 350 μl Buffer N3 (neutralization buffer) and mix immediately and 
thoroughly by inverting the tube 4-6 times 
- centrifuge at 13000 rpm for 10 minutes 
- apply the supernatant to the spin column by pipetting 
- centrifuge at 13000 rpm for 30 seconds, discard the flow-through 
- wash the spin column by adding 0,75 ml of Buffer PE and centrifuging at 
13000 for 30 seconds 
- discard the flow-through and spin for an additional 1 minute to remove 
residual wash buffer 
- place the spin column in a clean microcentrifuge tube 
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- to elute DNA add 50 ml water to the center of spin column, let stand for 1 
minute and centrifuge at 13000 rpm for 1 minute, usual concentration of 
DNA isolated by this method is 0,5 μg/μl 
 
16.2 DNA modifications 
 
Digestion by restriction endonucleases was done according to instructions 
provided by Roche and NEB companies and supplied reaction buffers were used.  
For ligation reactions was used T4 DNA Ligase (Roche) and supplied reaction 
buffer. T4 DNA ligase catalyzes the formation of phosphodiester bonds between 
neighbouring 3´-hydroxyl and 5´-phosphate ends in dsDNA. This enzyme will join 
blunt end and cohesive end termini as well as repair single stranded nicks in ds DNA. 
 
16.3 Agarose gel electrophoresis 
 
Agarose gel electrophoresis is a method used to separate DNA or RNA 
molecules by size. This is achieved by moving negatively charged nucleic acid 
molecules through an agarose matrix with an electric field. For estimating size and 
concentration of DNA on the gel was used 1 Kb Plus DNA Ladder (Invitrogen). 
 
Protocol: 
- dissolve 1% of agarose in 1x TBE by heating in microwave oven  
- after cooling down to approximately 60°C add ethidium bromide to final 
concentration 0,5 μg/ml 
- stir the solution to disperse the ethidium bromide, then pour it into the gel 
rack and insert the comb 
- when the gel has cooled down and become solid, remove the comb and put 
the gel with the rack into a tank with 1xTBE 
- load the samples mixed with Sample buffer for agarose gel electrophoresis 
- apply current, voltage 5 V/cm for approximately 1 hour 
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16.4 Isolation of DNA from the gel - QIAEX®II Gel extraction Kit 
(Qiagen) 
 
Extraction and purification of DNA fragments are based on solubilization of 
agarose and selective adsorption of DNA to the silica-gel particles in the presence of 
high salt. All impurities such as agarose, proteins, salts and ethidium bromide are 
removed during washing steps. Elution of the DNA is accomplished with a low-salt 
solution such as water. 
 
Kit contains: QIAEX II Suspension, Buffer QX1 and Buffer PE 
Protocol: 
- excise the DNA band from agarose gel with a clean scalpel 
- weigh the gel slice in a microcentrifuge tube and add 3 volumes of Buffer 
QX1 to 1 volume of gel 
- add 15 μl QIAEX II Suspension to the sample and mix 
- incubate at 50°C for 10 minutes, mix every 2 minutes to keep QIAEX II in 
suspension 
- centrifuge at 13000 rpm for 30 seconds, remove supernatant 
- wash the pellet with 500 μl of Buffer QX1 
- wash the pellet twice with  500 μl of Buffer PE 
- air-dry the pellet for 10 – 15 minutes until the pellet becomes white 
- to elute DNA add 20 μl of water, resuspend the pellet by vortexing and 
incubate in 50°C for 10 minutes 
- centrifuge at 13000 rpm for 30 seconds and save the supernatant 
 
16.5 QuikChange® Multi Site-Directed Mutagenesis Kit (Stratagene) 
 
The QuikChange® Multi site-directed mutagenesis kit offers a method for site-
directed mutagenesis of plasmid DNA at several different sites simultaneously. A 
single mutagenic oligonucleotide is required to mutagenize each site, using a dsDNA 
template and following three-step procedure. Step 1 uses a thermal cycling procedure 
to achieve multiple rounds of mutant strand synthesis. First the mutagenic primers 
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are annealed to denaturated template DNA. DNA polymerase then extends the 
mutagenic primers generating dsDNA molecules with one strand bearing multiple 
mutations and containing nicks. The nicks are sealed by components in the enzyme 
blend. In step 2, the thermal cycling reaction products are treated with DnpI 
restriction endonuclease, which is specific for methylated and hemimethylated DNA 
and is used to digest the parental DNA template. DNA isolated from almost all E. 
coli strains is dam methylated and therefore susceptible to digestion. In Step 3, the 
reaction mixture, enriched for mutated single stranded DNA, is transformed into 
XL10-Gold® ultracompetent cells, where the mutant ssDNA is converted into 
dsDNA in vivo. Plasmid DNA may then be isolated from the transformants and 
analyzed. 
  
Kit contains: QuikChange® Multi enzyme blend, 10x QuikChange® Multi reaction 
buffer, QuikSolution, dNTP Mix, DpnI restriction enzyme, XL10-Gold® 
ultracompetent cells, XL10-Gold® β-mercaptoethanol mix 
 
Protocol: 
Step 1 
- prepare the dsDNA template by standard miniprep protocol  
- prepare the mutant strand synthesis reactions for thermal cycling as indicated 
below 
10x QuikChange® Multi reaction buffer 2,5 μl 
QuikSolution 0,5 μl 
Template ds DNA 100 ng 
Primer 1 100 ng 
Primer 2 100 ng 
dNTP Mix 1 μl 
QuikChange® Multi enzyme blend 1 μl 
ddH2O to a final volume of 25 μl 
 
- cycle the reactions using the parameters below 
95°C 1 minute  
95°C 1 minute  
55°C 1 minute 30x 
65°C 2 minutes/kb of plasmid length  
4°C hold  
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Step 2 
- add 1,5 μl of DpnI to each amplification reaction, mix by pipetting and 
incubate at 37°C for 90 minutes 
Step 3 
- thaw the XL10-Gold® ultracompetent cells on ice 
- for each mutagenesis reaction to be transformed aliquot 45 μl of the 
ultracompetent cells to a prechilled microcentrifuge tube 
- add 2 μl of the β-ME mix to the cells 
- swirl the contents of the tube, incubate 10 minutes on ice swirling every 2 
minutes 
- add 5 μl of the DpnI – treated DNA from the mutagenesis reaction  
- swirl the transformation reaction and incubate on ice for 30 minutes 
- preheat SOC medium to 42°C 
- heat-pulse the tubes in a 42°C water bath for 30 seconds and then incubate on 
ice for 2 minutes 
- add 0,5 ml of preheated SOC medium and incubate at 37°C for 1 hour with 
shaking 
- plate the transformation reaction on LB/Amp plates 
 
16.6 Polymerase chain reaction (PCR) 
 
 Polymerase chain reaction was used to construct several recombinant vectors in 
this study. Typical PCR amplification program is shown below. Annealing 
temperature was adjusted according to the melting temperature of primers used in the 
reaction. Elongation time was adjusted according to the length of a fragment being 
amplified (1 minute/1kb length). 
 
Initial denaturation 95°C 5 minutes  
Denaturation 95°C 1 minute  
Annealing 55°C 1 minute 25x 
Elongation 72°C 1 minute  
Final elongation 72°C 5 minutes  
 4°C hold  
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Composition of PCR reactions: 1x ThermoPol Reaction Buffer (NEB), 800 μM 
dNTP mix (200 μM of each), ~20 ng template DNA, 2 μM primers, 1 Unit 
VentR® DNA Polymerase (NEB), ddH2O to a final volume of 50 μl. 
 
16.7 Sequencing 
 
All sequencing analysis were conducted at Centre Of DNA Sequencing at 
Institute of Microbiology, Academy of Science of Czech Republic. For sequencing 
reaction was used template DNA prepared by QIAprep Spin Miniprep Kit and 
specific primers in concentration 10 pmol/μl. The sequencing data were analyzed 
with BioEdit and Clone Manager programmes. 
 
16.8 Introducing DNA into target cells 
 
16.8.1 Transformation of E. coli by electroporation method 
 
 This method was used for introducing newly constructed vectors directly from 
the ligation reaction. 
 
Protocol: 
- thaw electrocompetent cells (EP-MAXTM 10B Competent Cells) on ice 
- mix 20 μl of the cells and 1 μl of the ligation reaction in a clean 
microcentrifuge tube 
- transfer the mixture into precooled electoporation cuvette 
- apply the pulse in the Gene Pulser Xcell Electroporation System using the „E. 
coli 1mm“ setting (conditions : 1,8 kV; 25 μF; 200 Ω) 
- immediately add 180 μl of SOC medium and transfer to a clean 
microcentrifuge tube 
- incubate for 30 minutes at 37°C with shaking 
- spread on LB/Amp plate 
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16.8.2 Transformation of E. coli by heat-shock method 
 
 This method was used for introducing plasmid DNA isolated by QIAprep Spin 
Miniprep Kit. 
 
Protocol: 
- thaw competent cells (Subcloning EfficiencyTM DH5αTM Competent Cells) 
on ice 
- mix 100 μl of the cells with 1 μl of plasmid DNA (500 ng) and icubate on ice 
for 30 minutes 
- heat shock cells at 42°C for 30 seconds 
- add 200 μl of SOC medium and incubate for 30 minutes at 37°C with shaking 
- spread on LB/Amp plate 
 
16.8.3 Transformation of S. cerevisiae by LiAC transformation method 
 
Protocol: 
- grow the S. cerevisiae strain you want to transform in 50 ml of liquid media 
(SD or YPD) to OD600 of approximately 0,5  
- centrifuge at 2500 rpm for 3 minutes and discard supernatant 
- wash the cells in 1 ml 1xLiAc/TE 
- resuspend the cells in 200 μl 1xLiAc/TE 
- add 20 μl of  Salmon sperm DNA (Invitrogen) 
- mix 50 μl of the cells with 1 μl of plasmid DNA (500 ng) and 300 μl 
PEG/LiAC/TE solution 
- incubate at 30°C for 30 minutes with shaking 
- incubate at 42°C for 15 minutes without shaking 
- add 1 ml dH2O and centrifuge at 2500 rpm for 3 minutes, discard supernatant 
- add 200 μl dH2O and spread on appropriate plate 
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17. Protein manipulation 
 
17.1 WCE preparation for Nickel affinity purification 
 
Protocol: 
- grow yeast cell culture in 100 ml of liquid media to OD600 of 1 
- centrifuge at 4000 rpm for 5 minutes at 4°C, discard supernatant 
- wash with 10 ml of ice cold dH2O 
- from this point always work on ice 
- resuspend the cells in 1 ml per gram (wet weight) of cells in BB buffer 
- add 4 mm diameter acid-washed glass beads equal to one half of the total 
volume of resuspended cells 
- vortex for 30 seconds followed by 1 minute on ice, repeat 5 times 
- centrifuge at 3000 rpm for 5 minutes at 4°C 
- transfer supernatant into precooled microcentrifuge tube 
- centrifuge at 13000 rpm for 2 minutes at 4°C  
- carefully transfer supernatant into new precooled microcentrifuge tube 
- centrifuge at 13000 rpm for 10 minutes at 4°C 
- save the supernatant 
 
17.2 WCE preparation for formaldehyde cross-linking followed by 
sucrose density gradient centrifugation experiment 
 
Protocol: 
- grow yeast cell culture in 100 ml of liquid media to OD600 of 1 
- put ice in a centrifuge tube ( 50 g per 100 ml of culture) 
- add culture and shake vigorously 
- immediately add 5,4 ml per 100 ml of culture of formaldehyde, shake and 
incubate on ice for 1 hour 
- add 10 ml per 100 ml of culture of 2,5M glycine and shake 
- centrifuge at 3500 rpm for 5 minutes at 4°C 
- resuspend the cells in 10 ml of GF buffer 
-  centrifuge at 2500 rpm for 3 minutes at 4°C 
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- resuspend the cells in 1 ml per gram (wet weight) of cells in GF buffer 
- add 4 mm diameter acid-washed glass beads equal to one half of the total 
volume of resuspended cells 
- vortex for 30 seconds followed by 1 minute on ice, repeat 8 times 
- centrifuge at 3000 rpm for 5 minutes at 4°C 
- transfer supernatant into precooled microcentrifuge tube 
- centrifuge at 13000 rpm for 2 minutes at 4°C  
- carefully transfer supernatant into new precooled microcentrifuge tube 
- centrifuge at 13000 rpm for 10 minutes at 4°C 
- save the supernatant 
 
17.3. SDS-PAGE 
 
Protocol: 
- mix samples for SDS-PAGE with 4x sample loading buffer and boil for 5 
minutes at 95°C 
- put Criterion Precast Gel into electroforetic tank and pour in SDS-PAGE 
running buffer 
- load samples on Criterion Precast Gel 
- load Precision Plus ProteinTM Standarts Dual Color (Bio-Rad) 
- apply current, voltage 200 V for 1 hour 
  
17.4 Western Blotting 
 
Protocol: 
- gel after SDS-PAGE wash with dH2O 
- assemble the blotting device (cathode, plastic net, sponge, filter paper, gel, 
nitrocellulose membrane, filter paper, 2 sponges, plastic net, anode) 
- fill the blotting tank with cool blotting buffer 
- apply current, voltage 25 V for 1,5 hour 
- reassemble the blotting device 
- incubate the membrane in blocking solution (5% milk in TBS-T) for 1 hour 
- cut the membrane apart if probing for different antibodies 
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- incubate every part of membrane with appropriate primary antibody diluted 
in blocking solution over night at 4°C 
- wash the membrane strips with TBS-T twice for 10 minutes 
- incubate the membrane strips with secondary antibody diluted in TBS-T for 1 
hour 
- wash the membrane strips with TBS-T twice for 10 minutes 
 
17.5 Chemiluminiscent detection 
 
Protocol: 
- assemble the membrane strips 
- incubate with SuperSignal West Femto Maximum Sensitivity Luminol and 
SuperSignal West Femto Maximum Sensitivity Stable Peroxidase Buffer (1:1 
solution) for 1 minute 
- take pictures in G:BOX iChemi 
 
17.6 Staining and drying of polyacrylamid gels 
 
Protocol: 
- after running SDS-PAGE wash the gel 5 minutes in water 
- incubate 1 hour with Gel Code® Blue Stain Reagent 
- destain 1 hour in water 
- put on wet filter paper and dry on gel dryer  
 
17.7 Purification of GST fused proteins 
 
Protocol: 
- inoculate in 5ml of LBAmp BL21 cells bearing desired pGEX plasmid and 
grow over night at 37°C 
- inoculate 2 ml from the overnight culture into 200ml of LBAmp, grow to 
OD600 of 0,7 
- induce by 1mM IPTG and grow 2 hours 
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- harvest cells by centrifugation at 4750 rpm for 14 minutes at 4°C and wash 
10 ml of ice cold water 
- resuspend in 10 ml of ice cold 1xPBS 
- sonicate 4x30s 
- add 0,5 ml of 20% TritonX-100 and rotate 30 min at 4°C 
- get rid of cell debris by centrifugation at 13000 rpm for 10 minutes in 4°C 
- add 400 μl of glutathion-Sepharose™ (50% slurry) to the supernatant and 
rotate for 30 minutes in room temperature 
- spin down at 1000 rpm for 5 minutes at 4°C 
- wash 3 times with 5 ml of ice cold 1xPBS 
- resuspend in 100 μl 1xPBS 
- make 20 ml aliquots and froze them at -80°C 
- use one aliquot for estimation of protein amount by SDS-PAGE: 4 dilutions 
of BSA (0,1 μg, 1 μg, 2 μg, 5 μg) and 1μl, 2 μl and 5 μl of the GST fusion 
protein 
 
17.8 TnT® Quick Coupled Transcription/Translation System 
(Promega) 
 
Protocol: 
- upon removal from storage at -80°C, rapidly thaw the TnT® Quick Master 
Mix by hand and place on ice 
- assemble the reaction components in a 0,5 ml microcentrifuge tube, gently 
mix by pipetting 
 
 Components Standard Reaction 
TnT® Quick Master Mix 40 μl 
[35S]methionine (1000Ci/mmol at 10mCi/ml) 2 μl 
DNA template (0,5 μg) 2,4 – 5 μl 
Nuclease-Free water to a final volume of  50 μl 
 
 
 
 
- incubate reaction at 30°C for 60-90 minutes 
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17.9 GST “pull-down“ experiment  
 
Protocol: 
- before use add 1mM DTT and 1% fat free powder milk to buffer B 
- for one reaction: 250 μl buffer B + GST fusion protein (1 – 5 μg; it should be 
the same amount of every GST fusion protein used in one assay; always make 
control with GST only) + 10 μl of TnT® reaction (17.8) 
- vortex at low rpm 
- incubate rotating for 2 hours in 4°C 
- spin down at 500 rpm for 2 minutes, remove supernatant 
- wash 3 times with 1 ml of ice cold 1xPBS 
- run SDS-PAGE with the entire reaction, always load 20% Input (2 μl of the 
TnT® reaction) 
- subject the dried gel to autoradiography 
 
17.10 Nickel affinity purification experiment 
 
Protocol: 
- estimate the total protein concentration (mg/ml) in WCE (17.1) using the Bio-
Rad Protein Assay Kit based on the Bradford dye-binding procedure 
(Bradford 1976) 
- use 1 mg of total protein for the assay; aliquot 5% of the total protein used in 
each reaction to provide the “Input” reference sample in the subsequent 
analysis (prepare for SDS-PAGE as in 17.3) 
- add  buffer BB up to 200 μl and 7,5 μl of Ni2+-NTA-silica resin (50% slurry) 
- rotate at 4°C over night 
- centrifuge the sample at 2200 rpm for 2 minutes to collect the resin 
- remove the “Flow-through” supernatant reserving a 5% aliquot 
- wash the resin 3 times with 1 ml of buffer BB 
- resuspend the resin in 50 μl of elution buffer E 
- vortex briefly and elute rotating for 20 minutes in 4°C 
- collect the resin by centrifugation and save the “Eluate” supernatant 
- analyze the purified proteins by SDS-PAGE and western blotting 
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17.11 Formaldehyde cross-linking followed by sucrose density 
gradient centrifugation experiment 
 
17.11.1 Sucrose density gradient preparation 
 
Protocol: 
- gradients should be prepared day before the main experiment 
- prepare Grad 30% and Grad 7,5% solutions according to the number of 
gradients you will use  
Grad 30% Grad 7,5%  
number of gradients 2 4 6 2 4 6 
GA solution 5 ml 9 ml 13 ml 15 ml 25 ml 35 ml 
GB solution 10 ml 18 ml 26 ml 3 ml 5 ml 7 ml 
1M DTT 15 μl 27 μl 39 μl 18 μl 30 μl 42 μl 
 
- label Beckman Polyallomer tubes using special labeling toll 
- put the tubes into a rack on the Gradient Master  
- load Grad 7.5 % solution with a syringe up to the mark 
- load Grad 30 % solution with a syringe under the Grad 7.5 % solution until 
the tube is full, this two solutions must not mix 
- put caps on the tubes 
- Run the Gradient Master (setting: Grad; SW41; 7,5-30%)  
- gently remove caps and put tubes into buckets 
- weigh the buckets with gradients and balance the opposite ones 
- store in 4°C over night 
 
17.11.2 Sucrose density gradient centrifugation experiment 
 
- measure the absorbance at 260 nm of WCE prepared in 17.2 (100x dilution) 
- count number of UNITS (absorbance x 100 = number of UNITS/ml) 
- take 1 UNIT as an 5% input, add 10 μl GF, prepare for SDS-PAGE as in 17.3 
and freeze for later use 
- take 20 UNITS to a clean microcentrifuge tube and add GF so that the 
opposite samples have a same volume 
 45
- carefully load samples on the top of the gradients so that the opposite ones 
are balanced 
- screw on the caps 
- put in the ultracentrifuge and run at 41000 rpm for 5 hours at 4°C in vacuum 
- after the centrifugation process the gradients using Brandel BR-188 Density 
Gradient Fractionation System, collect 12 fractions (600 μl each) 
- add 100 μl of 6x SDS-Loading Buffer to have 700 μl fractions and boil for 5 
minutes at 95°C 
- load 35 μl of the fractions on gel as in 17.3, do not forget to load the 5% input 
prepared earlier 
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Results 
 
 
18. Characterization of the HCR1-like domain (HLD) of the 
TIF32 subunit by “Domain swapping” 
 
As described above in chapter 6.3, HCR1 and the HLD of TIF32 share 
significant sequential and functional homology. This observation prompted an idea 
that these two domains might have a similar function and thus might be able to 
substitute for each other in vivo. To test this idea, two recombinant vectors were 
constructed: the first one bearing the HLD coding segment under control of the 
HCR1 promoter; and the second, carrying the TIF32 gene with its HLD replaced by 
full-length HCR1. Both constructs were introduced into S. cerevisiae H423 and H428 
strains deleted for TIF32 or HCR1 genes, respectively, and tested for functional 
complementation by plasmid shuffling. As shown in Fig. 11., the HLD alone 
expressed from the HCR1 promoter partially suppressed slow growth phenotype of 
the hcr1Δ strain. The chimeric TIF32-HCR1 protein was not able to support growth 
of the tif32Δ strain. These results that were not pursued further indicate that the HLD 
of TIF32 and HCR1 seem to share some functional similarity, the nature of which 
will to be explored in the future.  
 
18.1 Preparing of recombinant vectors YEpHCR1-DS, pRSTIF32-
His-DS, YEpHLD and pRSTIF32-HCR1-His 
 
 YEpHCR1-DS was constructed using the QuikChange® Multi Site-Directed 
Mutagenesis Kit (16.5) according to the vendor’s instructions. In step 1, PCR was 
performed with the kit-provided enzyme blend using primers DS HCR1-BHI and DS 
HCR1-NcoI, elongation time 14 minutes, and YEpLVHCR1 (Valášek et al. 1999) as 
a template. This subcloning step was done to introduce the BamHI site immediately 
preceding the ATG start codon and the NcoI site immediately followed by the stop 
codon of HCR1 to facilitate further cloning. Insertion of restriction sites was then 
verified by digestion with BamHI and NcoI. Since the strategy involves PCR 
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amplification of the entire plasmid, an 1289bp HindIII-SacI fragment containing the 
HCR1 gene was isolated from the mutagenized plasmid and used to replace the 
corresponding fragment in YEpLVHCR1 to produce YEpHCR1-DS. The entire 
HindIII to SacI fragment of YEpHCR1-DS was sequenced to confirm the presence of 
only the desired mutations. 
 pRSTIF32-His-DS was constructed using the QuikChange® Multi Site-
Directed Mutagenesis Kit according to the vendor’s instructions. In step 1, PCR was 
performed with the kit-provided enzyme blend using primers DS TIF32-BHI and DS 
TIF32-NcoI, elongation time 22 minutes, and pRSTIF32-His (Valášek et al. 2002) as 
a template. This subcloning step was done to introduce the BamHI site immediately 
followed by ATG start codon before Asp483 and NcoI site after Leu786 of TIF32 to 
facilitate further cloning. Insertion of restriction sites was then verified by digestion 
with BamHI and NcoI. Since the strategy involves PCR amplification of the entire 
plasmid, an 1655bp AatII-XbaI fragment containing the HLD was isolated from the 
mutagenized plasmid and used to replace the corresponding fragment in pRSTIF32-
His to produce pRSTIF32-His-DS. The entire AatII to XbaI fragment of pRSTIF32-
His-DS was sequenced to confirm the presence of only the desired mutations. 
 YEpHLD was constructed by inserting 921bp BamHI, NcoI fragment from 
pRSTIF32-His-DS into YEpHCR1-DS cleaved with BamHI, NcoI.  
pRSTIF32-HCR1-His was constructed by inserting 801bp BamHI, NcoI 
fragment from YEpHCR1-DS into pRSTIF32-His-DS cleaved with BamHI, NcoI.  
 
18.2 Testing phenotype of chimeric TIF32-HCR1 construct 
 
 Recombinant vector pRSTIF32-HCR1-His was introduced into H423 strain 
deleted for TIF32 by LiAC transformation. Transformed clones were selected on SD 
media lacking leucine and subsequently streaked out onto media containing 5-FOA 
to select for those that lost YCpTIF32-His, URA3-based covering plasmid. H423 
strain transformed with pRSTIF32-His and pRS315 were used as positive and 
negative control respectively. No clones were able to grow on 5-FOA, hence the 
TIF32-HCR1 chimeric protein does not support growth of tif32Δ strain.  
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18.3 Testing phenotype of HLD expressed alone from HCR1 
promoter 
 
 Recombinant vector YEpHLD was introduced into H428 strain deleted for 
HCR1 by LiAC transformation. Transformed clones were selected on SD media 
lacking leucine. H428 strain transformed with YEpLVHCR1 and YEplac181 were 
used as positive and negative control respectively. Resulting transformants were 
tested for various phenotypes and displayed an ability to suppress Slg- phenotype of 
hcr1Δ strain. As seen in Figure 11., YEpHLD did suppress the Slg- phenotype of 
H428 cells albeit only partially. To further document this finding, doubling times 
were measured for the tested strain and controls in 30°C and 37°C. Whereas the 
empty vector control increase doubling time by ~2-fold compared to wt, cells 
expressing the HLD in high copy showed reproducibly only ~1.5-fold increase at 
37°C (Tab. 2). 
   
 
 
 
 
 
 
FIGURE 11. HLD can partially suppress Slg- phenotype of hcr1Δ cells. H428 transformants with 
YEpLVHCR1, YEpHLD and YEplac181 were spotted in three serial 10-fold dilutions on SD medium 
and incubated in 37°C for 2 days. 
 
 
TABLE 2. Doubling times of H428 transformants in hours. WT – H428 transformed with 
YEpLVHCR1, HLD – H428 transformed with YEpHLD, EV – H428 transformed with YEplac181.
   
 
 30°C 37°C 
WT 2,71 h 2,15 h 
HLD 3,6 h 3,43 h 
EV 4,2 h 4,18 h 
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19. Genetic and biochemical analysis of the critical 
determinants of the interaction between the PRT1-RRM 
and HCR1 as determined by NMR spectroscopy 
 
 As mentioned in chapter 6.2, NMR analysis of our collaborating group of P.J. 
Lukavsky revealed that the human eIF3b-RRM forms a hydrophobic pocket in which 
the critical Trp residue of eIF3j resides (L. ElAntak and P.J. Lukavsky, unpublished 
observations). Given a lack of feasible methodology to study protein-protein 
interactions and their physiological roles in vivo in higher eukaryotes, we turned our 
attention to the yeast model that is notoriously known to provide a large arsenal of 
well-established in vivo methods. First we had to test whether or not the nature of 
binding between human eIF3b and eIF3j subunits has remained conserved also in 
yeast. To do that, several PRT1-RRM mutants targeting critical pocket residues were 
constructed (Tab.3) and tested for binding to HCR1 in vitro and in vivo. Mutations in 
loop5 (L5) and in helix α1 of PRT1-RRM disrupted binding of HCR1 in vitro (Fig. 
12.) and also eliminated HCR1 from MFC in vivo (Fig. 15.). Combined mutant α1L5 
showed Slg- phenotype at 37°C (Fig. 14) and also affected eIF3 association with 40S 
ribosome (Fig. 16). 
 
 
TABLE 3.  PRT1-RRM mutants created in this study 
Mutation Description 
PRT1-AALA in loop 5, 114HRLF to AALA 
PRT1-LFSK in helix α1, 62LFSK to AAAE 
PRT1-α1L5 in helix α1 and loop 5, 114HRLF to AALA and 
62LFSK to AAAE 
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19.1 Construction of recombinant vectors pRSPRT1-His-XS, 
pRSPRT1-AALA-His, pRSPRT1-LFSK-His and pRSPRT1-α1L5-
His 
 
To construct pRSPRT1-His-XS, the following pair of primers was used with 
pKHN45 (Nielsen et al., 2006) as a template : AH-PRT1-BamHI and AH-PRT1-
NotI-R. PCR product thus obtained was digested with BamHI-NotI and inserted into 
BamHI-NotI cleaved pKHN45. This subcloning step was done to remove the second 
XbaI and SpeI sites immediately following the stop codon of PRT1 to facilitate 
subcloning of the RRM mutants. 
pRSPRT1-AALA-His was generated by fusion PCR. The following two pairs 
of primers were used with pRSPRT1-His-XS as a template: AH-PRT1-ApaI and LV-
RRM-AALA-R; and LV-RRM-AALA and AH-PRT1-XbaI-R, respectively. The 
PCR products thus obtained were used in a 1:1 ratio as templates for a third PCR 
amplification with primers AH-PRT1-ApaI and AH-PRT1-XbaI-R. The resulting 
PCR product was digested with ApaI-XbaI and inserted into ApaI-XbaI cleaved pRS-
PRT1-His-XS producing pRSPRT1-AALA-His. The product was verified by 
restriction analysis and sequencing. 
pRSPRT1-LFSK-His was generated by fusion PCR. The following two pairs 
of primers were used with pRSPRT1-His-XS as a template: AH-PRT1-ApaI and AH-
PRT1-A1B-R; and AH-PRT1-A1B and AH-PRT1-XbaI-R respectively. The PCR 
products thus obtained were used in a 1:1 ratio as templates for a third PCR 
amplification with primers AH-PRT1-ApaI and AH-PRT1-XbaI-R. The resulting 
PCR product was digested with ApaI-XbaI and inserted into ApaI-XbaI cleaved pRS-
PRT1-His-XS producing pRSPRT1-LFSK-His. The product was verified by 
restriction analysis and sequencing. 
pRSPRT1-α1L5-His was generated by fusion PCR. The following two pairs 
of primers were used with pRSPRT1-AALA-His as a template: AH-PRT1-ApaI and 
AH-PRT1-A1B-R; and AH-PRT1-A1B and AH-PRT1-XbaI-R respectively. The 
PCR products thus obtained were used in a 1:1 ratio as templates for a third PCR 
amplification with primers AH-PRT1-ApaI and AH-PRT1-XbaI-R. The resulting 
PCR product was digested with ApaI-XbaI and inserted into ApaI-XbaI cleaved pRS-
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PRT1-His-XS producing pRSPRT1-α1L5-His. The product was verified by 
restriction analysis and sequencing. 
 
19.2 Constructing of recombinant vectors for GST pull-down 
experiment 
 
 PRT1-RRM mutants were cloned into pT7-7 (Tabor and Richardson 1987) 
vector under T7 promoter to be expressed in vitro by TnT® Quick Coupled 
Transcription/Translation System and tested for binding to GST fused HCR1. 
pT7-prt1-rrm-AALA was made by inserting the NdeI-HindIII digested PCR 
product obtained with primers LVPNDEI-724 and LVPC136-724 using the template 
pRSPRT1-AALA-His into NdeI-HindIII digested pT7-7. The product was verified 
by restriction analysis and sequencing. 
pT7-prt1-rrm-LFSK was made by inserting the NdeI-HindIII digested PCR 
product obtained with primers LVPNDEI-724 and LVPC136-724 using the template 
pRSPRT1-LFSK-His into NdeI-HindIII digested pT7-7. The product was verified by 
restriction analysis and sequencing. 
pT7-prt1-rrm-α1L5 was made by inserting the NdeI-HindIII digested PCR 
product obtained with primers LVPNDEI-724 and LVPC136-724 using the template 
pRSPRT1-α1L5-His into NdeI-HindIII digested pT7-7. The product was verified by 
restriction analysis and sequencing. 
 
19.3 Isolating GST-fused HCR1 and GST proteins for GST pull-
down experiment 
 
 Plasmids pGEX-5x-3 and pGEX-HCR1 contain GST and GST fused HCR1 
respectively under tac promoter, which is inducible by IPTG. After addition of IPTG 
to the growth media, proteins are expressed in high amounts.  
 Bacteria E. coli BL21 carrying this vectors were grown in LB media and then 
induced with IPTG. GST and GST-HCR1 proteins were isolated as described in 
chapter 17.7. 
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19.4 In vitro binding assay – “GST pull-down” 
  
 To investigate whether the critical determinants of PRT1–HCR1 interaction in 
yeast are similar in nature to those in humans, all three PRT1-RRM mutants and wild 
type PRT1-RRM were expressed in vitro by TnT® Quick Coupled 
Transcription/Translation System (17.8), labeled with 35S-methionine and tested for 
in vitro binding to GST fused HCR1. GST alone was used as a negative control. 
Neither of RRM mutants retained the ability to bind to HCR1 in vitro (Fig. 12) 
clearly illustrating that all the tested residues critically contribute to the PRT1-RRM 
– HCR1 protein-protein interaction. 
 
FIGURE 12. In vitro binding assay. Upper box displays amounts of GST and GST-HCR1 in each 
reaction. Lower box shows the same gel area after autoradiography. Only wt RRM was able to bind to 
GST-HCR1 (lane 4). (lane 1) Protein ladder, (lane 2,5,8,11) 20% Input of the TnT® reaction. 
 
 
19.5 Testing phenotypes of PRT1-RRM mutants 
 
Recombinant vectors pRSPRT1-AALA-His, pRSPRT1-LFSK-His and 
pRSPRT1-α1L5-His were introduced into H425 strain deleted for PRT1 by LiAC 
transformation. Transformed clones were selected on SD media lacking leucine and 
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subsequently grown on media containing 5-FOA to select for those that lost the 
CR52 (Cigan et al. 1991) URA3-based covering plasmid. All mutant strains formed 
colonies on 5-FOA suggesting that neither mutation is lethal. H425 strain 
transformed with wt pRSPRT1-His and empty vector pRS315 were used as positive 
and negative controls, respectively.  
Whereas the PRT1-AALA and PRT1-LFSK alleles showed no detectable 
growth defects (Fig.13), combination of both in PRT1-α1L5 displayed Slg- 
phenotype at 37°C (Fig. 14) suggesting that the pocket residues are functionally 
important. 
 
 
 
FIGURE 13. H425 transformants with pRSPRT1-His, pRSPRT1-AALA-His and pRSPRT1-LFSK-
His were spotted in four serial 10-fold dilutions on SD medium and incubated in 37°C for 3 days. 
Neither of mutants showed any visible phenotype. 
 
 
 
FIGURE 14. H425 transformants with pRSPRT1-His and pRSPRT1-α1L5-His were spotted in four 
serial 10-fold dilutions on SD medium and incubated in 37°C for 3 days. PRT1-α1L5 mutant 
displayed slow growth phenotype. 
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19.6 “Nickel pull-down” 
 
Effect of the PRT1-RRM mutations on the formation of entire eIF3-
containing MFC was analyzed by Ni2+ chelation chromatography using His8-tagged 
PRT1 as a bait (see chapter 17.10). WCEs from transformants of the H425 strain 
expressing individual PRT1-RRM mutants were incubated with Ni-NTA silica resin 
and analyzed by SDS-PAGE followed by western blotting. H425 transformed with 
pRSPRT1-His and original H425 strain bearing untagged PRT1 were used as 
positive and negative controls, respectively. All tested MFC components copurified 
specifically with wt PRT1, as expected, but not with its untagged version. In contrast,  
all tested PRT1-RRM mutations specifically eliminated only HCR1 from MFC (Fig. 
15), suggesting that mutated pocket residues are important for binding of HCR1, but 
not for the stability of MFC. 
 
 
IN    E1       E2    W 
FIGURE 15. The helix α1 and loop 5 of PRT1-RRM are required for HCR1 association with MFC in 
vivo. WCEs were prepared from H425 bearing untagged PRT1 (lanes 1 to 4), and H425 transformants 
with pRSPRT1-His (lanes 5 to 8), pRSPRT1-AALA-His (lanes 9 to 12), pRSPRT1-LFSK-His (lanes 
13 to 16) and pRSPRT1-α1L5-His (lanes 17 to 20). Lanes 1, 5, 9, 13 and 17 contained 5% of the input 
WCEs (IN); lanes 2, 6, 10, 14 and 18 contained 30% of fractions eluted from the resin (E1); lanes 3, 7, 
11, 15 and 19 contained 60%  of fractions eluted from the resin (E2); lanes 4, 8, 12, 16 and 20 
contained 5% of the flow through (wash, W). 
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19.7 eIF3 association with 40S ribosome 
 
 To examine if the α1L5 mutation, disrupting the direct contact with HCR1, 
also affects association of mutant eIF3 with the 40S ribosome, binding of selected 
eIF3 subunits and other MFC components to the 40S was measured in WCEs 
obtained by formaldehyde cross-linking (Fig. 16.). H425 transformants with 
pRSPRT1-α1L5-His and pRSPRT1-His were grown in SD medium at 37°C to an 
OD600 of ~1,5 and cross-linked with 2% HCHO prior to harvesting. WCE were 
prepared and subsequently separated on a 7,5% - 30% sucrose gradient by 
centrifugation at 41,000 rpm for 5 hours. Proteins from the collected fractions were 
subjected to Western analysis. Based on quantification of the Western signals, we 
observed ~45% decrease in the amounts of selected eIF3 subunits associated with 
40S ribosomes in WCEs obtained from the α1L5 cells compared to the wild type 
control. Similar but less pronounced reductions were also observed for eIF2 (~30%) 
and eIF5 (~25%). Amounts of the 40S-associated HCR1 were reduced only 
marginally (~15%). 
 
    IN     top    3         4         5       6      7        8        9      10      11      12 
 
FIGURE 16.  Destroying of the hydrophobic pocket of the PRT1-RRM reduces eIF3-binding to 40S 
ribosomes. (A) Strain H425 transformed with pRSPRT1-His, (B) Strain H425 transformed with 
pRSPRT1-α1L5-His. An aliquot of each WCE was analyzed in parallel (IN, 5% input); first two 
fractions were combined (top). Mean proportions of the total proteins found in fractions 10-11, 
calculated using NIH ImageJ from two independent experiments are shown in the right column. The 
calculations were done by Leoš Valášek, PhD.  
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Discussion 
 
 
20. What do the sequential homologues in HCR1 and the 
HLD of TIF32 have in common? 
 
The HLD domain of TIF32, sharing a significant sequential homology with 
HCR1 (6.3), was found to be able to partially suppress the Slg- phenotype of hcr1Δ 
cells when expressed from the HCR1 endogenous promoter on a high copy plasmid 
(Fig. 11). Susan Wagner from our laboratory has recently found that the C-terminal 
domain (CTD) of HCR1 specifically interacts with the TIF32-HLD and is entirely 
dispensable for wt growth unless combined with the rpg1-1 mutation in TIF32 (this 
mutation occurs in the most homologous motif between HCR1 and the HLD called 
KERR – see chapter 6.3). In addition, both the HCR1-CTD and TIF32 are able to 
interact with the same ribosomal protein RPS2 occurring in the mRNA entry channel 
on the solvent side of the small ribosomal subunit (S. Wagner and L. Valášek, 
unpublished observations). These findings might suggest that the TIF32-HLD and 
the HCR1-CTD form a heterodimer, where they closely cooperate to perform an 
important function possibly involving mutual binding to RPS2. We speculate that 
this important function is probably somehow involved in mRNA recruitment to the 
40S ribosome and/or subsequent scanning for the AUG start codon. Hence it is 
conceivable to suggest that the HLD domain expressed alone could form a pseudo-
heterodimer with the internal HLD of TIF32 and thus partly substitute for HCR1 in 
the latter role.  
Alternatively, besides TIF32, HCR1 binds also to the PRT1-RRM and might 
serve to stabilize their mutual interaction (Valášek et al. 2001b). Hence a partial 
suppression exerted by the HLD could also be explained by proposing that the HLD 
alone is capable of stabilizing the latter contact that is believed to be crucial for the 
MFC integrity (Valášek et al. 2001a). 
Apart from translation initiation, HCR1 has been also shown to promote 40S 
ribosome biogenesis (Valášek et al., 2001b). Since the TIF32 roles seem to be 
restricted to translation initiation, it is highly unlikely that the HLD domain would 
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suppress a defect in ribosome biogenesis that is also caused by HCR1 deletion. 
Nevertheless, to clearly rule out this possibility, polysome profile analysis combined 
with pulse chase experiments detecting 40S biogenesis intermediates would need to 
be carried out.  
On the other hand, the fact that the chimeric TIF32-HCR1 protein did not 
support growth of tif32Δ strain does not necessarily mean that HCR1 can not 
substitute for the HLD’s functions. The simplest interpretation of this negative result 
could be in improper folding of the chimeric TIF32 protein with HCR1 inserted in 
place of HLD. Taking into account that TIF32 is an essential protein, its larger 
missfolding would logically result in non viability. 
Even though our data further extended an earlier believe that besides sequential 
homology, HCR1 and the HLD of TIF32 are also similar in function to some degree, 
more experimental data are certainly required to fully address the role of both of 
these eIF3 parts in translation initiation. Our laboratory in collaboration with the 
group of Alan G. Hinnebusch from NIH in Bethesda are currently striving to resolve 
this puzzle in a set of complementary approaches. 
 
 
21. Defining the critical determinants of the PRT1-RRM-
HCR1 interaction and their role in translation initiation 
 
eIF3 plays critical roles in virtually all stages of translation initiation, during 
reinitiation, post-termination ribosomal recycling, and nonsense-mediated decay 
pathway (Hinnebusch, 2006; Pisarev et. al., 2007; Szamecz et. al., 2008; Isken et. al., 
2008). In order to understand how the numerous functions of eIF3 are encoded in its 
conserved subunits and their interactions, high-resolution structural studies of 
protein-protein interactions of eIF3 subunits are imminent. Our collaborators from 
MCR in Cambridge revealed by NMR spectroscopy a first structure of an interaction 
among eIF3 subunits, between human eIF3b-RRM and eIF3j-NTD (L. ElAntak and 
P.J. Lukavsky, unpublished observations) (Fig. 8.). This interaction is driven by 
conserved charge complementarity between the subunits and an evolutionary 
conserved hydrophobic pocket on the backside of the eIF3b-RRM, which 
accommodates the strictly conserved Trp residue in the eIF3j-NTD.  
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My findings that specific mutations targeting the conserved residues of the 
hydrophobic pocket of the yeast eIF3b/PRT1-RRM disrupted its direct binding to 
eIF3j/HCR1 in vitro (Fig. 12.) and completely eliminated HCR1-association with the 
MFC in vivo (Fig. 15.) clearly point at the high evolutionary conservation of this 
interaction. It is noteworthy that the fact that the loss of HCR1 did not seem to 
significantly affect occurrence of TIF32 and PRT1 in the MFC (Fig. 15.) contradicts 
the theory mentioned in the previous chapter that HCR1 stabilizes their mutual 
contact required for the MFC stability and, hence, favors our pseudo-heterodimer 
idea. High degree of evolutionary conservation has gained further support by the 
recent data of Susan Wagner from our laboratory who showed that mutating the 
critical Trp and its neighboring acidic residues in HCR1 has the same effect as 
mutations in the pocket residues (S. Wagner and L. Valášek, unpublished 
observations).  
Taken together, it is no surprise that the pocket residue mutations turned out to 
be important for viability of cells, as the combined α1L5 mutant displayed Slg- 
phenotype when grown at higher temperature (Fig. 14.). Since HCR1 is able to bind 
to 40S subunit on its own (Phan et al., 2001), it’s elimination from the MFC does not 
necessarily need to cause any growth defect, providing that it will still be capable of 
carrying out its 40S-associated functions in close co-operation with other 40S-bound 
eIF3 subunits and MFC components. However, the α1L5 mutant significantly 
reduced 40S-association of the core subunits of eIF3 as well as eIFs 2 and 5 in vivo 
as shown by the formaldehyde cross-linking experiment (Fig. 16.). Even though 
HCR1 was able to bind to 40S subunit nearly to the same extend as in the wild type 
cells, as expected (Fig. 16.), it probably failed to fulfill its roles due to reduced 
ribosome-occupancy of eIF3.  
Taken together, these findings indicate that the hydrophobic pocket of the 
PRT1-RRM is not important only for anchoring HCR1 to eIF3 but perhaps plays 
even more critical role in 40S-association of the whole eIF3 complex by creating yet 
another intermolecular bridge between eIF3 and 40S in addition to that already 
described in case of the TIF32-NTD (Valášek et al., 2003, Szamecz et al., 2008). 
What function(s) the evolutionary well conserved interaction between HCR1 and the 
PRT1-RRM performs on the 40S ribosome is again a subject of extensive studies in 
our laboratory.  
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 Conclusions 
 
 
The initiation of translation in eukaryotes requires the coordinated action of at 
least 12 eukaryotic initiation factors (eIFs). Among them, eIF3 deserves a special 
attention owing to a broad range of functions that it is believed to promote. The 
research conducted here aimed at bringing a closer insight into functions of specific 
domains of several eIF3 subunits and the interactions among them. The middle HLD 
domain of TIF32 was proposed to share not only sequential but also functional 
homology with HCR1 as it was able to partially substitute for the loss of 
chromosomal copy of HCR1 when expressed alone under control of HCR1 promoter.  
Based on unpublished determination of the interaction interface between the 
RRM of human eIF3b/PRT1 and eIF3j/HCR1 by NMR spectroscopy in the 
laboratory of P.J. Lukavsky, we confirmed biochemically that also in yeast the 
conserved Trp residue in the N-terminal segment of HCR1 binds to the hydrophobic 
pocket of the PRT1-RRM formed by the helix α1 and the loop L5. This interaction 
was shown to be required for association of HCR1 with the rest of the MFC but not 
with the 40S ribosome. Besides evolutionary conservation of this contact and its 
importance for HCR1 binding to eIF3, the hydrophobic pocket residues turned out to 
be also required for anchoring the whole eIF3 to the small ribosomal subunit. 
Detailed investigation of physiological roles of the eIF3 domains studied here, 
namely TIF32-HLD, PRT1-RRM and HCR1, as a part of the mutually interacting 
module of eIF3 is one of the main interests in our laboratory and, as a matter of fact, 
elucidation of molecular nature of functions of the RRM and the extreme C-terminal 
domains of PRT1 promoting its eIF3-scaffolding role will be the main goal of my 
doctoral thesis. 
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